This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of pretomanid: A Synthesis of Findings from 14 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of pretomanid: A Synthesis of Findings from 14 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Gabapentin and pregabalin have antiallodynic and antihyperalgesic properties that are useful for treating neuropathic pain. These properties may also be beneficial in acute postoperative pain. This study evaluated randomized, controlled trials examining the analgesic efficacy, adverse effects, and clinical value of gabapentinoids in postoperative pain. 3

Pregabalin, a new antiepileptic drug, does not impair eye control or posture control, unlike the established antiepileptic drug carbamazepine, as shown in a prospective study on healthy volunteers. 4

A randomized controlled trial found that preoperative pregabalin does not reduce the amount of propofol needed for general anesthesia induction. 8

A meta-analysis showed that perioperative pregabalin administration can reduce postoperative pain and the need for postoperative analgesics. However, it also increases the risk of dizziness, lightheadedness, and visual disturbances. 6

A double-blind study in healthy volunteers showed that pregabalin did not affect sleep quality compared to alprazolam or placebo. 1

Two large-scale, placebo-controlled trials found that pregabalin improved both pain and pain-related sleep interference in patients with neuropathic pain due to spinal cord injury (SCI). 9

A randomized double-blind placebo-controlled trial found that adding pregabalin to multimodal analgesic therapy after ankle surgery reduced the duration of moderate to severe pain in the first 24 hours following foot or ankle surgery. 7

Gabapentin and pregabalin are being explored as nonhormonal treatment options for vasomotor symptoms, which are common in postmenopausal women and patients receiving hormone deprivation therapies. 14

A double-blind placebo-controlled trial in healthy volunteers showed that 12 weeks of pregabalin administration did not affect cognitive function. 5

Pregabalin is a new neuromodulator with a wide range of therapeutic indications, including neuropathic pain, epilepsy, and anxiety. 2

A systematic review with meta-analyses and trial sequential analyses found that pregabalin may have a minimal opioid-sparing effect, but the risk of serious adverse events seems increased. 13

Several case reports and epidemiological studies have raised concerns about the abuse potential of pregabalin, whose use has increased substantially in recent years. 11

Pregabalin, when combined with remifentanil, has analgesic, ventilatory, and cognitive effects. 10

Patients with neuropathic pain often receive combination therapy with multiple agents to improve both pain and any comorbidities. 12

Benefits and Risks

Benefit Summary

Pregabalin may be beneficial in reducing postoperative pain, decreasing the need for postoperative analgesics, improving neuropathic pain, and treating vasomotor symptoms. 6 , 13 , 14

Risk Summary

Pregabalin can increase the risk of dizziness, lightheadedness, visual disturbances, and serious adverse events. There is also concern about its potential for abuse. 6 , 13 , 11

Comparison of Studies

Commonalities

Multiple studies have suggested that pregabalin can be effective in reducing postoperative pain and neuropathic pain. 6 , 9 , 13

Differences

The effectiveness of pregabalin in managing postoperative pain has been inconsistent across studies, and a definitive conclusion has not been reached. 6 , 7 , 13

Consistency and Discrepancies in Results

While pregabalin shows potential benefit in reducing postoperative pain and treating neuropathic pain, its effectiveness is not consistently observed, and further research is needed. 13

Considerations for Real-World Application

Although pregabalin can be helpful in managing postoperative pain and neuropathic pain, it comes with the risk of side effects such as dizziness, lightheadedness, and visual disturbances. Therefore, pregabalin should be used cautiously and under the guidance of a doctor. 6 , 13

Limitations of Current Research

Further research is needed to better understand the long-term effects of pregabalin and its effectiveness in different diseases and situations. 13

Future Research Directions

Large-scale, long-term studies are needed to clarify the effects of pregabalin. 13

Conclusion

Pregabalin shows promise in managing postoperative pain and neuropathic pain, but its effectiveness is not consistent, and further research is needed. Pregabalin should be used cautiously and under the guidance of a doctor. 6 , 13


Literature analysis of 14 papers
Positive Content
10
Neutral Content
1
Negative Content
3
Article Type
7
5
4
3
14

Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.